Antibiotic prescription in intensive care units in Latin America;Prescripción de antibióticos en unidades de cuidados intensivos de Latinoamérica

Revista Argentina de Microbiologia

Volumn 43, Issue 3, 2011, Pages 203-211

  Curcio, Daniel J ^a   Curcio, Daniel ^b   Alí, Abraham ^c   Duarte, Alejandro ^d   Defilippi Pauta, Alfredo ^e   Guerrón, Alvaro Fernando Erazo ^f   Bañales Churrut, Ana ^g   Salcedo, Blanca ^h   Paz Chávez, Carlos Humberto ⁱ   Ibáñez Guzmán, Carlos ^j   Maldonado, Carlos Rebolledo ^k   Alvarado Cueto, Daniel ^l   López García, David ^m   Yepes, David ⁿ   Labarca, Eduardo ^o   Veloz, Electra Moreno ^p   Valencia, Erick ^k   Plano, Fabian ^q   Varón, Fabio ^c   Toapanta, Fausto Guerrero ^r   Paredes Oña, Fernando ^s   Arancibia, Francisco ^t   Molina Saldarriaga, Francisco ^u   Montufar Andrade, Franco ^v   Morales Alava, Freddy ^w   Cañarte Bermudez, Gleinner ^x   La Fuente Zerain, Gustavo ^y   Caballero Narváez, Henry ^z   Ramos Palomino, Iván ^aa   Villasante, Juan Salas ^ab   Villalobos Vindas, Juan ^ac   Castagnino, Jorge ^ad   Espitaleta Gómez, Jorge ^ae   Ranero Meneses, Jorge ^af   Rojas Suarez, José ^ag   Carlos Fernández Mercado, Juan ^ag   Guzmán Torrico, José ^ah   Vergara Centeno, José ^e   Carlos Medina, Juan ^ai   Durán Pérez, Julio ^aj   Marín, Karina ^h   Alba Caero, Lenny ^ak   Crespo, Leonardo Durán ^al   Ferreira Cabrera, Leonina ^am   Castillo Bravo, Luis ^an   Soto Germani, Luis ^ao   Carvajal Herrera, Martín ^ap   Oyanguren, Martin ^aq   Chung Sang, Miguel ^ar   Llano, Miguel ^as   Játiva, Mijail ^at   Oliveros, Norma Ruiz ^au   López Acosta, Oscar ^av   Cotes, Rafael ^aw   Thomen, Rafael ^ax   Mendoza Franco, Ray ^ay   Belloni, Ramón ^az   Morales, Ricardo ^ba   Romero, Ricardo ^bb   Aguilera Perrogón, Rolando ^bc   Camacho Alarcón, Ruben ^bd   Camargo, Ruben ^be   Cevallos, Stenio ^bf   Salva Sutherland, Stevens ^bg   Alanis Mirones, Victor ^bh   Figueroa, Víctor ^h   Intriago Cedeño, Virginia ^bi   Romero, Viviana ^bj   Jensen, Werner ^bk   Urbina Contreras, Zulma ^bl   Socorro Morales, Alfonso ^bm   Rivero Mendoza, Arnoldo ^bn   Tomicic Flores, Vinko ^bo   more..

^a Instituto Sacre Coeur ^*

^b Instituto Sacre Coeur   (Argentina)

^c FUNDACIÓN CARDIOINFANTIL INSTITUTO DE CARDIOLOGÍA   (Colombia)

^d Hospital Regional Rio Grande   (Argentina)

^e HOSPITAL LUIS VERNAZA   (Ecuador)

^f Hospital Quito Nro 1 Policía Nacional   (Ecuador)

^g HOSPITAL SAN JOSÉ   (Chile)

^h Hospital Oncológico Solón Espinosa Ayala   (Ecuador)

ⁱ Hospital Central de la Fuerza Aerea y Clinica San Gabriel   (Peru)

^j Hospital Obrero No 1   (Bolivia)

^k Clínicas SaludCoop   (Colombia)

^l Clínica Madre Bernarda   (Colombia)

^m Hospital Universitario San Vicente de Paul   (Colombia)

ⁿ Universidad Pontificia Bolivariana   (Colombia)

^o Hospital Naval Almte Nef   (Chile)

^p Hospital de Infectología Dr Daniel Rodriguez Maridueña   (Ecuador)

^q Hospital Privado Modelo   (Argentina)

^r HOSPITAL CARLOS ANDRADE MARÍN   (Ecuador)

^s Hospital de Clínicas Pichincha   (Ecuador)

^t INSTITUTO NACIONAL DEL TÓRAX   (Chile)

^u Clinica Universitaria Bolivariana   (Colombia)

^v HOSPITAL PABLO TOBÓN URIBE   (Colombia)

^w Hospital Oncológico Dr Julio Villacreses Colmont   (Ecuador)

^x Hospital IEES de Portoviejo   (Ecuador)

^y Hospital Universitario Japonés   (Bolivia)

^z Hospital Enrique Garcés   (Ecuador)

^aa UCHG   (Ireland)

^ab HOSPITAL REGIONAL DOCENTE DE TRUJILLO   (Peru)

^ac Hospital México   (Costa Rica)

^ad Sanatorio de la Providencia   (Argentina)

^ae Hospital San Rafael   (Costa Rica)

^af Inst Guatemalteco Seguridad S   (Guatemala)

^ag Gestión Salud SA and Grupo de Investigación en Cuidados Intensivos y Obstetricia   (Colombia)

^ah Centro Médico Quirurgico Boliviano Belga   (Bolivia)

^ai Sanatorio Itoiz   (Argentina)

^aj UNIVERSIDAD DEL NORTE   (Colombia)

^ak Hospital Clínico Viedma   (Bolivia)

^al Medico de planta del Hospital Obrero Nro 2 de la Caja Nacional de Salud   (Bolivia)

^am Hospital Guillermo Grant Benavente   (Chile)

^an INSTITUTO NACIONAL DE ENFERMEDADES NEOPLÁSICAS   (Peru)

^ao Hospital de San Pablo   (Chile)

^ap Clínica Medihelp Services   (Colombia)

^aq HOSPITAL NACIONAL EDGARDO REBAGLIATI MARTINS   (Peru)

^ar Clinica Guayaquil and Hospital Militar de Guayaquil   (Ecuador)

^as Hospital General de las Fuerzas Armadas   (Ecuador)

^at HOSPITAL EUGENIO ESPEJO   (Ecuador)

^au Hospital Militar de Caracas   (Venezuela)

^av Clínica Martha   (Colombia)

^aw Clínica Sur   (Colombia)

^ax Clínica La Asunción   (Colombia)

^ay Hospital Consorcio Gestión UCI   (Colombia)

^az Sanatorio Guemes   (Argentina)

^ba Facultad de Medicina   (Chile)

^bb Instituto Del Corazon   (Argentina)

^bc Hospital Obrero Nro 3   (Bolivia)

^bd Clínica San Gregorio and Hospital IESS Manta   (Ecuador)

^be Clínica General del Norte   (Colombia)

^bf Hospital Alcivar   (Ecuador)

^bg Hospital de Clinicas Caracas   (Venezuela)

^bh Hospital Universitario San Juan de Dios   (Bolivia)

^bi Hospital Verdi Cevallos Balda   (Ecuador)

^bj Hospital Padre Pedro Tardivo   (Argentina)

^bk Hospital Dr Gustavo Fricke   (Chile)

^bl Clinica Universitaria del Norte de Santander   (Colombia)

^bm Hospital Dr Manuel Noriega Trigo   (Venezuela)

^bn Hospital Dr Miguel Oraa   (Venezuela)

^bo UNIVERSIDAD DEL DESARROLLO   (Chile)

more..

Author keywords

Carbapenem; Drug resistance; Latin America; lactamases

Indexed keywords

CEFEPIME; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; ENTEROBACTERIACEAE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PSEUDOMONAS AERUGINOSA; SEPTIC SHOCK; SOUTH AND CENTRAL AMERICA; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 80053059966     PISSN: 03257541     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0325-75412011000300007     Document Type: Article

References (54)

1. Alvarez C, Cortes J, Arango A, Correa C, Leal A; Grupo para el Control de la Resistencia Bacteriana en Bogotá. Antimicrobial resistance in intensive care units in Bogotá, Colombia, 2001-2003. Rev Salud Publica (Bogotá) 2006; Suppl 1: 86-101.
2. Ansari F, Erntell M, Goossens H, Davey P. The European surveillance of antimicrobial consumption (ESAC) pointprevalence survey of antibacterial use in 20 European hospitals in 2006. Clin Infect Dis 2009; 49: 1496-504.
3. Bantar C, Famiglietti A, Goldberg M. Three-year surveillance study of nosocomial bacterial resistance in Argentina. The Antimicrobial Committee; and the National Surveillance Program (SIR) Participants Group. Int J Infect Dis 2000; 4: 85-90.
4. Bantar C, Famiglietti A, Radice M, Quinteros M, Antimicrobial Committee; SIR Participants Group. Participants Group. A 7-year national survey on bacterial resistance in bronchoalveolar lavage from patients hospitalized in Argentina. Diagn Microbiol Infect Dis 2008; 60: 65-9.
5. Bergmans DC, Bonten MJ, Gaillard CA, van Tiel FH, van der Geest S, de Leeuw PW, Stobberingh EE. Indications for antibiotic use in ICU patients: a one-year prospective surveillance. J Antimicrob Chemother 1997; 39: 527-35.
6. Celis R, Torres A, Gatell JM, Almela M, Rodriguez-Roisin R, Agusti-Vidal A. Nosocomial pneumonia. A multivariate analysis of risk and prognosis. Chest 1988; 93: 318-24.
7. Chow JW, Fine MJ, Shlaes DM, Quinn JP, Hooper DC, Johnson MP, Ramphal R, Wagener MM, Miyashiro DK, Yu VL. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991; 115: 585-90.
8. Clinical and Laboratory Standard Institute. Clinical and Laboratory Standard Methods. Performance Standards for Antimicrobial Susceptibility Testing, 17th Informational Supplement; 2007; M100-S17. Wayne, PA. EE. UU.
9. Curcio D, Alí A, Duarte A, Defilippi Pauta A, Ibáñez-Guzmán C, Chung Sang M, Latin American Antibiotic Use in Intensive Care Unit Group. Prescription of antibiotics in intensive care units in Latin America: an Observational Study. J Chemother 2009; 21: 41-8.
10. Cuthbertson BH, Thompson M, Sherry A, Wright MM, Bellingan GJ; Intensive Care Society. Antibiotic-treated infections in intensive care patients in the UK. Anaesthesia 2004; 59: 885-90.
11. Erlandsson M, Burman LG, Cars O, Gill H, Nilsson LE, Walther SM, Hanberger H; Strama-Icu Study Group. Prescription of antibiotic agents in Swedish intensive care units is empiric and precise. Scand J Infect Dis 2007; 39: 63-9.
12. Fagon JY, Chastre J, Domart Y, Trouillet JL, Pierre J, Darne C, Gibert C. Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. Am Rev Respir Dis 1989; 139: 877-84.
13. Fridkin SK, Steward CD, Edwards JR, Pryor ER, McGowan JE Jr, Archibald LK, Gaynes RP, Tenover FC. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis 1999; 29: 245-52.
14. Fujimura S, Nakano Y, Sato T, Shirahata K, Watanabe A. Relationship between the usage of carbapenem antibiotics and the incidence of imipenem-resistant Pseudomonas aeruginosa. J Infect Chemother 2007; 13: 147-50.
15. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1998; 16: 128-40.
16. Hanssens Y, Ismaeil BB, Kamha AA, Elshafie SS, Adheir FS, Saleh TM, Deleu D. Antibiotic prescribing pattern in a medical intensive care unit in Qatar. Saudi Med J 2005; 26: 1269-76.
17. Harris AD, McGregor JC, Johnson JA, Strauss SM, Moore AC, Standiford HC, Hebden JN, Morris JG Jr. Risk factors for colonization with extended-spectrum beta-lactamaseproducing bacteria and intensive care unit admission. Emerg Infect Dis 2007; 13: 1144-9.
18. Hidayat LK, Hsu DI, Quist R, Shriner KA, Wong-Beringer A. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch Intern Med 2006; 166: 2138-44.
19. Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Bilker WB, Lautenbach E. Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae: variability by site of infection. Arch Intern Med 2005; 165: 1375-80.
20. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118: 146-55.
21. Iosifidis E, Antachopoulos C, Tsivitanidou M, Katragkou A, Farmaki E, Tsiakou M, Kyriazi T, Sofianou D, Roilides E. Differential correlation between rates of antimicrobial drug consumption and prevalence of antimicrobial resistance in a tertiary care hospital in Greece. Infect Control Hosp Epidemiol 2008; 29: 615-22.
22. Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000; Suppl 4: S131-S138.
23. Kollef MH. Hospital-acquired pneumonia and de-escalation of antimicrobial treatment. Crit Care Med 2001; 29: 1473-5.
24. Kollef MH. Providing appropriate antimicrobial therapy in the intensive care unit: surveillance vs. de-escalation. Crit Care Med 2006; 34: 903-5.
25. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999; 115: 462-74.
26. Krieg NR, Holt JG. Bergeýs Manual of Systematic Bacteriology, Volume 1. Baltimore, MD, USA: Williams & Wilkins, 1984.
27. Landman D, Quale JM, Mayorga D, Adedeji A, Vangala K, Ravishankar J, Flores C, Brooks S. Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned. Arch Intern Med 2002; 162: 1515-20.
28. Lodise TP, Lomaestro B, Graves J, Drusano GL Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity. Antimicrob Agents Chemother 2008; 52: 1330-6.
29. Lodise TP, Miller CD, Graves J, Evans A, Graffunder E, Helmecke M, Stellrecht K. Predictors of high vancomycin MIC values among patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 2008; 62: 1138-41.
30. Lodise TP, Graves J, Evans A, Graffunder E, Helmecke M, Lomaestro BM, Stellrecht K. Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob Agents Chemother 2008; 52: 3315-20.
31. Luna CM, Vujacich P, Niederman MS, Vay C, Gherardi C, Matera J, Jolly EC. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997; 111: 676-85.
32. Mentzelopoulos SD, Pratikaki M, Platsouka E, Kraniotaki H, Zervakis D, Koutsoukou A, Nanas S, Paniara O, Roussos C, Giamarellos-Bourboulis E, Routsi C, Zakynthinos SG. Prolonged use of carbapenems and colistin predisposes to ventilator-associated pneumonia by pandrug-resistant Pseudomonas aeruginosa. Intensive Care Med 2007; 33:1524-32.
33. Moise-Broder PA, Forrest A, Birmingham MC, Schentag JJ. Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin Pharmacokinet 2004; 43: 925-42.
34. Monnet DL, Archibald LK, Phillips L, Tenover FC, McGowan JE Jr, Gaynes RP. Antimicrobial use and resistance in eight US hospitals: complexities of analysis and modeling. Intensive Care Antimicrobial Resistance Epidemiology Project and National Nosocomial Infections Surveillance System Hospitals. Infect Control Hosp Epidemiol.1998; 19: 388-94.
35. Monteiro J, Santos AF, Asensi MD, Peirano G, Gales AC. First report of KPC-2-producing Klebsiella pneumoniae strains in Brazil. Antimicrob Agents Chemother 2009; 53: 333-4.
36. Nguyen HB, Rivers EP, Havstad S, Knoblich B, Ressler JA, Muzzin AM, Tomlanovich MC. Critical care in the emergency department: A physiologic assessment and outcome evaluation. Acad Emerg Med 2000; 7: 1354-61.
37. Parker CM, Kutsogiannis J, Muscedere J, Cook D, Dodek P, Day AG, Heyland DK; Canadian Critical Care Trials Group. Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes. J Crit Care 2008; 23: 18-26.
38. Pasteran FG, Otaegui L, Guerriero L, Radice G, Maggiora R, Rapoport M, Faccone D, Di Martino A, Galas M. Klebsiella pneumoniae carbapenemase-2, Buenos Aires, Argentina. Emerg Infect Dis 2008; 14: 1178-80.
39. Peirano G, Seki LM, Val Passos VL, Pinto MC, Guerra LR, Asensi MD. Carbapenem-hydrolysing beta-lactamase KPC-2 in Klebsiella pneumoniae isolated in Rio de Janeiro, Brazil. J Antimicrob Chemother 2009; 63: 265-8.
40. Petersen IS, Hesselbjerg L, Jørgensen L, Renstrup J, Barnung S, Schierbeck J, Jepsen OB. High antibiotic consumption in Danish intensive care units? APMIS 1999; 107: 989-96.
41. Rello J, Gallego M, Mariscal D, Sonora R, Valles J. The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med 1997; 156: 196-200.
42. Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis 2008; 197: 1079-81.
43. Richards GA. The therapeutic challenge of Gram-negative sepsis: prolonging the lifespan of a scarce resource. Clin Microbiol Infect 2005; Suppl 6: 18-22.
44. Røder BL, Nielsen SL, Magnussen P, Engquist A, Frimodt-Møller N. Antibiotic usage in an intensive care unit in a Danish university hospital. J Antimicrob Chemother 1993; 32: 633-42.
45. Rogues AM, Dumartin C, Amadéo B, Venier AG, Marty N, Parneix P, Gachie JP. Relationship between rates of antimicrobial consumption and the incidence of antimicrobial resistance in Staphylococcus aureus and Pseudomonas aeruginosa isolates from 47 French hospitals. Infect Control Hosp Epidemiol 2007; 28: 1389-95.
46. Rybak MJ, Lomaestro BM, Rotschafer JC, Moellering RC, Craig WA, Billeter M, Dalovisio JR, Levine DP. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis 2009; 49: 325-7.
47. Sader HS, Jones RN, Gales AC, Silva JB, Pignatari AC; SENTRY Participants Group (Latin America). SENTRY antimicrobial surveillance program report: Latin American and Brazilian results for 1997 through 2001. Braz J Infect Dis 2004; 8: 25-79.
48. Saurina G, Quale JM, Manikal VM, Oydna E, Landman D Antimicrobial resistance in Enterobacteriaceae in Brooklyn, NY: epidemiology and relation to antibiotic usage patterns. J Antimicrob Chemother 2000; 45: 895-8.
49. Schurink CA, Hoitsma M, Rozenberg-Arska M, Joore JC, Hoepelman IM, Bonten MJ. Do cultures contribute to optimisation of antibiotic therapy in the intensive care unit? Int J Antimicrob Agents 2004; 23: 325-31.
50. TEST program (Tigecycline Evaluation and Surveillance Trial). http://www.testsurveillance.com; accessed January 7, 2009.
51. Tognim MC, Andrade SS, Silbert S, Gales AC, Jones RN, Sader HS. Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance Program. Int J Infect Dis 2004; 8: 284-91.
52. Villegas MV, Lolans K, Correa A, Kattan JN, Lopez JA, Quinn JP. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase. Antimicrob Agents Chemother 2007; 51: 1553-5.
53. Villegas MV, Lolans K, Correa A, Suarez CJ, Lopez JA, Vallejo M, Quinn JP. First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob Agents Chemother 2006; 50: 2880-2.
54. Warren MM, Gibb AP, Walsh TS. Antibiotic prescription practice in an intensive care unit using twice-weekly collection of screening specimens: a prospective audit in a large UK teaching hospital. J Hosp Infect 2005; 59: 90-5.